Ubs Group Ag Galera Therapeutics, Inc. Transaction History

Ubs Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.14 - $0.27 $39,380 - $75,947	281,287 Added 2302.8%	293,502 $41,000
Q4 2023 Feb 09, 2024	BUY	$0.09 - $0.27 $1,099 - $3,298	12,215 New	12,215 $1,000
Q2 2023 Aug 11, 2023	BUY	$2.5 - $3.42 $20,920 - $28,618	8,368 New	8,368 $26,000
Q2 2022 Aug 10, 2022	SELL	$1.24 - $2.39 $7,688 - $14,818	-6,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.01 - $4.19 $245 - $511	122 Added 2.01%	6,200 $15,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $8.28 $7,719 - $50,325	6,078 New	6,078 $28,000
Q3 2021 Nov 15, 2021	SELL	$7.04 - $10.49 $1,999 - $2,979	-284 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.08 - $10.44 $24,715 - $42,438	-4,065 Reduced 93.47%	284 $3,000
Q1 2021 May 12, 2021	BUY	$8.35 - $12.39 $19,981 - $29,649	2,393 Added 122.34%	4,349 $38,000
Q4 2020 Feb 11, 2021	BUY	$8.02 - $12.81 $9,319 - $14,885	1,162 Added 146.35%	1,956 $20,000
Q3 2020 Nov 12, 2020	SELL	$6.96 - $9.12 $14,685 - $19,243	-2,110 Reduced 72.66%	794 $7,000
Q2 2020 Jul 31, 2020	BUY	$7.14 - $14.41 $13,558 - $27,364	1,899 Added 188.96%	2,904 $21,000
Q1 2020 May 01, 2020	SELL	$5.89 - $17.67 $14,041 - $42,125	-2,384 Reduced 70.35%	1,005 $10,000
Q4 2019 Feb 14, 2020	BUY	$9.13 - $13.9 $30,941 - $47,107	3,389 New	3,389 $45,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $805K
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.